BioNano Genomics Hires Garth Monroe as CFO

"Bringing Garth aboard is the next step in the evolution of BioNano Genomics as a solution provider for researchers who want to fully understand the biology of the genomes at the core of their research," said BioNano Genomics President and CEO Dr. R. Erik Holmlin. "He will provide considerable financial leadership to our company as we commercialize and grow."

Prior to joining BioNano Genomics, Mr. Monroe served as CFO for Epocal, a multi-national, venture-backed medical device company. There, he played an integral role in the $255 million sale of the company to Alere(TM). Mr. Monroe previously served as station manager for JetBlue Airways and a financial analyst at United Technologies. He is a certified public accountant and holds a Bachelor of Science in Business Administration from the University of Connecticut and a Master of Business Administration from the University of Virginia, Darden School of Business.

"I am very enthusiastic about the opportunity to help Bionano Genomics carry out the vision for financial growth and commercialization," added Mr. Monroe.